Erratum: Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024))

Laura M. Amendola, Gail P. Jarvik, Michael C. Leo, Heather M. McLaughlin, Yassmine Akkari, Michelle D. Amaral, Jonathan S. Berg, Sawona Biswas, Kevin M. Bowling, Laura K. Conlin, Greg M. Cooper, Michael O. Dorschner, Matthew C. Dulik, Arezou A. Ghazani, Rajarshi Ghosh, Robert C. Green, Ragan Hart, Carrie Horton, Jennifer J. Johnston, Matthew S. LeboAleksandar Milosavljevic, Jeffrey Ou, Christine M. Pak, Ronak Y. Patel, Sumit Punj, Carolyn (Sue) Richards, Joseph Salama, Natasha T. Strande, Yaping Yang, Sharon E. Plon, Leslie G. Biesecker, Heidi L. Rehm

Research output: Contribution to journalComment/debate

40 Citations (Scopus)

Abstract

(The American Journal of Human Genetics 98, 1067–1076; June 2, 2016) On page 1072 in the originally published version of this article, PS2 was a typo and should have read PS3 in the following sentence: “The other most common examples of modified strength included the following: PVS1 (a predicted null variant in a gene where LOF is a known mechanism of disease) was downgraded from very strong four times, PS2 (well-established functional studies show a deleterious effect) was downgraded three times, and BS1 (MAF is too high for the disorder) was downgraded three times.” The error has been corrected online, and the authors apologize for the oversight.

Original languageEnglish (US)
Pages (from-to)247
Number of pages1
JournalAmerican Journal of Human Genetics
Volume99
Issue number1
DOIs
StatePublished - Jul 7 2016

Fingerprint

Medical Genetics
Adenosine Monophosphate
Guidelines
Research
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Erratum : Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024)). / Amendola, Laura M.; Jarvik, Gail P.; Leo, Michael C.; McLaughlin, Heather M.; Akkari, Yassmine; Amaral, Michelle D.; Berg, Jonathan S.; Biswas, Sawona; Bowling, Kevin M.; Conlin, Laura K.; Cooper, Greg M.; Dorschner, Michael O.; Dulik, Matthew C.; Ghazani, Arezou A.; Ghosh, Rajarshi; Green, Robert C.; Hart, Ragan; Horton, Carrie; Johnston, Jennifer J.; Lebo, Matthew S.; Milosavljevic, Aleksandar; Ou, Jeffrey; Pak, Christine M.; Patel, Ronak Y.; Punj, Sumit; Richards, Carolyn (Sue); Salama, Joseph; Strande, Natasha T.; Yang, Yaping; Plon, Sharon E.; Biesecker, Leslie G.; Rehm, Heidi L.

In: American Journal of Human Genetics, Vol. 99, No. 1, 07.07.2016, p. 247.

Research output: Contribution to journalComment/debate

Amendola, LM, Jarvik, GP, Leo, MC, McLaughlin, HM, Akkari, Y, Amaral, MD, Berg, JS, Biswas, S, Bowling, KM, Conlin, LK, Cooper, GM, Dorschner, MO, Dulik, MC, Ghazani, AA, Ghosh, R, Green, RC, Hart, R, Horton, C, Johnston, JJ, Lebo, MS, Milosavljevic, A, Ou, J, Pak, CM, Patel, RY, Punj, S, Richards, CS, Salama, J, Strande, NT, Yang, Y, Plon, SE, Biesecker, LG & Rehm, HL 2016, 'Erratum: Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024))', American Journal of Human Genetics, vol. 99, no. 1, pp. 247. https://doi.org/10.1016/j.ajhg.2016.06.001
Amendola, Laura M. ; Jarvik, Gail P. ; Leo, Michael C. ; McLaughlin, Heather M. ; Akkari, Yassmine ; Amaral, Michelle D. ; Berg, Jonathan S. ; Biswas, Sawona ; Bowling, Kevin M. ; Conlin, Laura K. ; Cooper, Greg M. ; Dorschner, Michael O. ; Dulik, Matthew C. ; Ghazani, Arezou A. ; Ghosh, Rajarshi ; Green, Robert C. ; Hart, Ragan ; Horton, Carrie ; Johnston, Jennifer J. ; Lebo, Matthew S. ; Milosavljevic, Aleksandar ; Ou, Jeffrey ; Pak, Christine M. ; Patel, Ronak Y. ; Punj, Sumit ; Richards, Carolyn (Sue) ; Salama, Joseph ; Strande, Natasha T. ; Yang, Yaping ; Plon, Sharon E. ; Biesecker, Leslie G. ; Rehm, Heidi L. / Erratum : Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024)). In: American Journal of Human Genetics. 2016 ; Vol. 99, No. 1. pp. 247.
@article{5e3bf4f4869c4299afb9f224cf460fb9,
title = "Erratum: Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024))",
abstract = "(The American Journal of Human Genetics 98, 1067–1076; June 2, 2016) On page 1072 in the originally published version of this article, PS2 was a typo and should have read PS3 in the following sentence: “The other most common examples of modified strength included the following: PVS1 (a predicted null variant in a gene where LOF is a known mechanism of disease) was downgraded from very strong four times, PS2 (well-established functional studies show a deleterious effect) was downgraded three times, and BS1 (MAF is too high for the disorder) was downgraded three times.” The error has been corrected online, and the authors apologize for the oversight.",
author = "Amendola, {Laura M.} and Jarvik, {Gail P.} and Leo, {Michael C.} and McLaughlin, {Heather M.} and Yassmine Akkari and Amaral, {Michelle D.} and Berg, {Jonathan S.} and Sawona Biswas and Bowling, {Kevin M.} and Conlin, {Laura K.} and Cooper, {Greg M.} and Dorschner, {Michael O.} and Dulik, {Matthew C.} and Ghazani, {Arezou A.} and Rajarshi Ghosh and Green, {Robert C.} and Ragan Hart and Carrie Horton and Johnston, {Jennifer J.} and Lebo, {Matthew S.} and Aleksandar Milosavljevic and Jeffrey Ou and Pak, {Christine M.} and Patel, {Ronak Y.} and Sumit Punj and Richards, {Carolyn (Sue)} and Joseph Salama and Strande, {Natasha T.} and Yaping Yang and Plon, {Sharon E.} and Biesecker, {Leslie G.} and Rehm, {Heidi L.}",
year = "2016",
month = "7",
day = "7",
doi = "10.1016/j.ajhg.2016.06.001",
language = "English (US)",
volume = "99",
pages = "247",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024))

AU - Amendola, Laura M.

AU - Jarvik, Gail P.

AU - Leo, Michael C.

AU - McLaughlin, Heather M.

AU - Akkari, Yassmine

AU - Amaral, Michelle D.

AU - Berg, Jonathan S.

AU - Biswas, Sawona

AU - Bowling, Kevin M.

AU - Conlin, Laura K.

AU - Cooper, Greg M.

AU - Dorschner, Michael O.

AU - Dulik, Matthew C.

AU - Ghazani, Arezou A.

AU - Ghosh, Rajarshi

AU - Green, Robert C.

AU - Hart, Ragan

AU - Horton, Carrie

AU - Johnston, Jennifer J.

AU - Lebo, Matthew S.

AU - Milosavljevic, Aleksandar

AU - Ou, Jeffrey

AU - Pak, Christine M.

AU - Patel, Ronak Y.

AU - Punj, Sumit

AU - Richards, Carolyn (Sue)

AU - Salama, Joseph

AU - Strande, Natasha T.

AU - Yang, Yaping

AU - Plon, Sharon E.

AU - Biesecker, Leslie G.

AU - Rehm, Heidi L.

PY - 2016/7/7

Y1 - 2016/7/7

N2 - (The American Journal of Human Genetics 98, 1067–1076; June 2, 2016) On page 1072 in the originally published version of this article, PS2 was a typo and should have read PS3 in the following sentence: “The other most common examples of modified strength included the following: PVS1 (a predicted null variant in a gene where LOF is a known mechanism of disease) was downgraded from very strong four times, PS2 (well-established functional studies show a deleterious effect) was downgraded three times, and BS1 (MAF is too high for the disorder) was downgraded three times.” The error has been corrected online, and the authors apologize for the oversight.

AB - (The American Journal of Human Genetics 98, 1067–1076; June 2, 2016) On page 1072 in the originally published version of this article, PS2 was a typo and should have read PS3 in the following sentence: “The other most common examples of modified strength included the following: PVS1 (a predicted null variant in a gene where LOF is a known mechanism of disease) was downgraded from very strong four times, PS2 (well-established functional studies show a deleterious effect) was downgraded three times, and BS1 (MAF is too high for the disorder) was downgraded three times.” The error has been corrected online, and the authors apologize for the oversight.

UR - http://www.scopus.com/inward/record.url?scp=84989958164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989958164&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2016.06.001

DO - 10.1016/j.ajhg.2016.06.001

M3 - Comment/debate

AN - SCOPUS:84989958164

VL - 99

SP - 247

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -